feed,title,long_url,short_url
Benzinga,"Bausch health announces vyzultaÂ® (latanoprostene bunod ophthalmic solution), 0.024%, is now approved in seven countries",https://www.benzinga.com/pressreleases/20/09/g17633760/bausch-health-announces-vyzulta-latanoprostene-bunod-ophthalmic-solution-0-024-is-now-approved-in-,https://j.mp/2RTgkUH
